Position in TEVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$203,693,847
+$166,415,069 QoQ
Shares Held
6,762,744
+466.2% QoQ
Ownership
0.581%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,485,768 across 61 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in TEVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $203,693,847 | 6,762,744 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $37,278,778 | 1,194,450 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $27,979,217 | 1,385,110 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $29,186,798 | 1,741,456 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $32,491,731 | 2,113,971 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $65,885,245 | 2,989,349 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $36,435,731 | 2,021,961 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $81,778,381 | 5,032,516 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $42,437,483 | 3,007,618 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $22,053,243 | 2,112,380 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $9,789,651 | 959,770 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,376,271 | 1,112,387 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $11,256,310 | 1,271,900 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $5,575,608 | 611,361 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $4,879,523 | 604,650 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,045,614 | 537,981 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $5,120,279 | 545,291 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $4,916,502 | 613,796 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $5,750,610 | 590,412 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $18,550,588 | 1,873,797 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $39,799,599 | 3,448,839 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $27,752,303 | 2,875,887 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $38,609,305 | 4,285,162 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $34,268,652 | 2,779,291 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $32,162,369 | 3,581,556 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||